H40.843

Clinical Causes: Diabetes mellitus, particularly proliferative diabetic retinopathy Severe retinal ischemia or lack of oxygen to the retina Ocular vascular conditions like central retinal vein occlusion Eye tumors or inflammations that stimulate abnormal blood vessel growth Previous eye surgeries or injuries that disrupt normal blood flow

Key Symptoms: Gradual loss of peripheral or central vision Seeing halos or rainbows around lights Eye redness and swelling Eye pain or discomfort Reduced light tolerance or sensitivity Sudden increase in intraocular pressure causing nausea and headache (in some cases)

Diagnosis Path: Diagnosis involves comprehensive eye examinations, including: - Measurement of intraocular pressure - Gonioscopy to examine the drainage angle - Slit-lamp biomicroscopy to observe abnormal blood vessels - Fundus examination to inspect the retina - Imaging tests like fluorescein angiography to detect retinal ischemia and neovascularization Timely assessment is essential for detecting neovascularization and determining the extent of angle closure.

Treatment Protocols: Managing neovascular secondary angle closure glaucoma aims to control eye pressure, reduce abnormal blood vessel growth, and address underlying causes. Common approaches include: - Medical therapy with eye drops to lower intraocular pressure, such as prostaglandin analogs, beta-blockers, or carbonic anhydrase inhibitors - Panretinal photocoagulation (laser treatment) to reduce retinal ischemia and discourage new blood vessel formation - Anti-vascular endothelial growth factor (anti-VEGF) injections to inhibit abnormal blood vessel growth - Surgical procedures like trabeculectomy or drainage implants if medical and laser therapies are insufficient - Treatment of underlying systemic conditions, especially diabetes management Close monitoring and comprehensive treatment are critical to preserving vision and preventing further eye damage.